InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: Biostockclub post# 166408

Saturday, 09/22/2018 6:23:27 AM

Saturday, September 22, 2018 6:23:27 AM

Post# of 462185
Biostock:

Biogen is a Gold Sponsor of the CTAD (highest level). They did not change their time slot nor issue a PR, like last time.
They will capitulate. Not at the conference - the CEO is not scheduled to be there at the presentation (and that’s a CEO announcement - ending a trial)...this has a much different tenor than last time. That was their strong arm approach. I believe this time they come in peace and are ready to report mediocre results, while letting us and our big guns have the spotlight. I think they want us to shine...it will make the case much more compelling for their shareholders when the big deal goes through. They are selling the acquisition to their investors now, imo. It’s their smartest move.

Know why our trial hasn’t appeared on the AUS registry yet? Cause it’s the Enola Gay...just doing a fly by, in case needed...but it shouldn’t be.

They will stand down the troops and prepare to sign the treaty. Treaties are good things. After you surrender, don’t forget, your enemy helps you REBUILD your forces and repair your damages! And, the FDA comes along with them. We can offer our pearl(s) of inestimable value. They can offer us a ton (and I mean ton!) of cash, help with FDA approvals, US trials, many trials, and infrastructure to manufacture, market, and sales/distribution for our products.



Excellent stuff. Your top guy observation is brilliant. We shall see.

Musashi wrote: "The pen and the sword, in accord". The BIIB top guy would be foolish to further complicate things at this point. Hanging on to the Amyloid thesis at this point is a senseless marker of sorts. He is getting some bad guidance from somewhere while he tries to manage from a position of strength. Some gesture of reconciliation before CTAD would be smart and would go a long way. I expect this will happen even if we have no idea what it is publicly. Samurai would only fight (die) if a deal could not be made and then only after very carefully studying the skills of his opponent, sometimes in competitions designed specifically a plan to demonstrate/compare skills. (see analogy somewhere).

Precision medicine has already defined the future, we just don't know it yet. Some have recognized that and others are waiting for guidance and of course there isn't any, except for HH and team who have been studying/working/waiting to do this for years. It will take a while for even the best minds to catch up and by then AVXL will have established critical BP leadership skills. I am not trained to understand details but I think the Precision Medicine process will lead to each patient having their own unique CNS micro analysis w/treatments custom designed for them. I also believe that every one of us is on some AD/dementia curve which must eventually be appropriately treated and that Precision Medicine practices will get us all to the next level, or else.
BR
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News